✦ LIBER ✦

Diverse FOXP3 Expression in Children with Type 1 Diabetes and Celiac Disease

✍ Scribed by Anna Kivling; Lennart Nilsson; Karin Fälth-Magnusson; Sofia Söllvander; Calle Johanson; Maria Faresjö

Book ID: 111484816
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 134 KB
Volume: 1150
Category: Article
ISSN: 0890-6564
DOI: 10.1196/annals.1447.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Annual screening detects celiac disease

Annual screening detects celiac disease in children with type 1 diabetes

✍ Karin Larsson; Annelie Carlsson; Elisabeth Cederwall; Björn Jönsson; Jan Neideru 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Celiac disease prevalence in children an

Celiac disease prevalence in children and adolescents with type 1 diabetes from Serbia

✍ Zlatko Djurić; Hristina Stamenković; Tatjana Stanković; Radovan Milićević; Ljilj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Validated protocol for FoxP3 reveals inc

Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients

✍ Jean Grant; Katarzyna Bourcier; Stephen Wallace; Dalin Pan; Alexis Conway; Vicki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Symptomless celiac disease in type 1 dia

Symptomless celiac disease in type 1 diabetes: 12-year experience in Estonia

✍ Oivi Uibo; Kaire Heilman; Tiina Rägo; Riina Shor; Mare Paal; Kaja Metsküla; Vall 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Microvascular disease in children and ad

Microvascular disease in children and adolescents with type 1 diabetes and obesity

✍ M. Loredana Marcovecchio; Francesco Chiarelli 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 199 KB

Poor in vitro induction of FOXP3 and ICO

Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes

✍ Jarno Honkanen; Susanne Skarsvik; Mikael Knip; Outi Vaarala 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract ## Background Type 1 diabetes (T1D) is characterised by loss of tolerance to beta‐cell antigens, and the insulin‐producing beta‐cells in the pancreatic islets are destroyed by the host's own immune system. Immunological risk factors associated with T1D are related to the defects in the